Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
2022
Recommendations for a standard on corporate biodiversity measurement and valuation, ALIGN
El proyecto Align ha publicado recomendaciones que aportan más claridad sobre "qué" elementos de la biodiversidad medir y "cómo" evaluar…
2023
Demonstrating Business Action for Nature
Las principales empresas de todos los sectores y zonas geográficas ya están adoptando las medidas de alto nivel y siendo…
EU Nature Toolkit
This practical guide will help readers understand why nature is important. It begins by proposing a journey that begins by…